Healthy high growth potential

Results

1500

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1500 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
AV1
AU$0.08310.7%-27.8%AU$68.6mAU$0.178.0108.4%n/aSoftware
688700
CN¥91.90-7.9%138.1%CN¥26.8bCN¥53.67184.757.4%0.2%Capital Goods
688270
CN¥73.20-10.5%127.5%CN¥21.8bCN¥185.71145.985.5%0%Semiconductors
002709
CN¥56.346.6%210.1%CN¥109.6bCN¥65.0839.928.9%0.4%Materials
6223
NT$7,145.0011.3%672.4%NT$654.5bNT$7,502.73190.255.5%0.3%Semiconductors
MX1
AU$0.034-8.1%-24.4%AU$25.5mAU$0.151.5105.5%n/aHealthcare
688072
CN¥820.0010.8%443.0%CN¥216.7bCN¥511.08140.335.2%0.04%Semiconductors
002970
CN¥62.33-8.8%29.1%CN¥11.5bn/a34.836.5%1.6%Automobiles
688183
CN¥136.61-3.2%188.2%CN¥104.4bCN¥146.0065.532.6%0.7%Tech
1729
HK$19.27-4.2%155.6%HK$43.2bHK$25.0054.933.6%0.2%Capital Goods
1860
HK$11.10-14.9%49.2%HK$17.8bHK$18.2629.241.1%n/aMedia
3881
HK$22.86-1.9%n/aHK$10.1bn/a9.8107.6%n/aCapital Goods
6990
HK$422.404.7%28.5%HK$92.8bHK$547.6441.544.8%n/aPharmaceuticals & Biotech
2315
HK$42.586.5%90.1%HK$40.4bHK$62.0256.840.4%n/aPharmaceuticals & Biotech
2171
HK$13.91-10.6%-41.1%HK$9.4bHK$21.1457.180.6%n/aPharmaceuticals & Biotech
002810
CN¥26.065.8%119.0%CN¥8.7bCN¥36.0045.243.1%1.5%Materials
001389
CN¥184.00-10.6%229.4%CN¥84.8bCN¥218.0074.433.2%0.4%Tech
002384
CN¥257.130.08%605.4%CN¥464.8bCN¥136.67229.768.4%0%Tech
605376
CN¥224.506.8%465.9%CN¥58.6bCN¥120.50241.744.4%0.04%Materials
300432
CN¥22.11-5.1%68.0%CN¥37.8bCN¥34.4074.660.7%0.5%Automobiles
688192
CN¥39.818.8%-34.8%CN¥17.9bCN¥91.3820.7105.8%n/aPharmaceuticals & Biotech
A458870
₩33,900.00-2.9%335.5%₩1.1t₩69,000.0042.441.5%n/aHealthcare
VIKRAMSOLR
₹190.22-9.3%n/a₹68.9b₹246.6014.730.0%n/aSemiconductors
MIDWESTLTD
₹1,292.60-0.06%n/a₹46.6b₹1,500.0044.659.3%n/aMaterials
Page 1 of 42